<DOC>
	<DOCNO>NCT00665106</DOCNO>
	<brief_summary>Evaluation safety tolerability single injection NOVA63035 `` Corticosteroid '' administer one four dose patient diabetic macular edema ( DME ) secondary diabetic retinopathy</brief_summary>
	<brief_title>Safety Tolerability NOVA63035 `` Corticosteroid '' Patients With Diabetic Macular Edema Secondary Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>M &amp; F 18 year old Diagnosed diabetes mellitus present diabetic retinopathy Monocular History current ocular hypertension glaucoma either eye define Any significant ocular disease ( diabetic retinopathy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetic macular edema</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Diabetic retinopathy</keyword>
</DOC>